Status:
COMPLETED
REWARDS Premier Taxus-Liberte vs Xience V
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Multicenter, retrospective registry to collect baseline, clinical, procedural, in hospital and 9-12 month follow-up data to compare major adverse cardiac events in patients receiving Promus Premier dr...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Underwent PCI with Promus Premier (alone) DES
Exclusion
- Underwent PCI with a non-Promus Premier DES during the same index procedure
- Patients not taking, or unable to take, dual antiplatelet therapy (aspirin plus clopidogrel, prasugrel, or ticagrelor)
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
917 Patients enrolled
Trial Details
Trial ID
NCT02256527
Start Date
September 1 2014
End Date
October 1 2015
Last Update
July 14 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010